Dollar Tree makes 3 leadership changesThe appointments follow the resignation of Rick Dreiling as chairman and CEO as of Nov. 3. Cigna reportedly not buying HumanaCigna said it “remains committed to its established M&A criteria and would only consider acquisitions that are strategically aligned, financially attractive, and have a high probability to close,” per a WSJ report. Bora Pharmaceuticals acquires Pyros Pharmaceuticals Pyros is a specialty pharmaceutical company developing treatments for rare diseases. SpartanNash taps Djouma Barry as SVP, chief retail officer Barry brings retail strategy and operations experience from Kroger, Target, Old Navy and Lululemon. Formosa, DÁVI ink deal for clobetasol propionate ophthalmic suspension Clobetasol propionate ophthalmic suspension is used to treat inflammation and pain following ocular surgery. Lundbeck to acquire Longboard Longboard is a clinical-stage biopharmaceutical company focused on developing medicines for neurological diseases. Aurobindo obtains FDA OK for generic Keflet Cephalexin tablets are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms. Kenvue taps Andrew Stanleick as president of skin health & beauty, North America, Europe, Middle East, Africa Stanleick will lead the strategic direction of Kenvue's portfolio of brands, including Neutrogena, Aveeno and OGX, in the regions. Dollar Tree CEO Rick Dreiling steps down Michael C. Creedon Jr. has been appointed interim CEO upon Rick Dreiling's stepping down as chairman and CEO, effective Nov. 3 due to health challenges. Shields, Sutter Health expand collaboration for patient access to specialty pharmacy services This pharmacy collaboration aims to expand care to patients who receive specialty medications to help treat chronic, rare and complex conditions. First Previous 6 7 8 9 10 Next Last
